Experimental drug reverses paralysis, vision loss in multiple sclerosis model (IMAGE)
Caption
The experimental drug, Kamuvudine K-9, is a derivative of HIV drugs already approved for use in patients. It was developed by Jayakrishna Ambati, MD, founding director of the University of Virginia's Center for Advanced Vision Science and the DuPont Guerry III Professor in the UVA School of Medicine’s Department of Ophthalmology.
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the experimental MS drug. All other uses require express written consent from UVA Health.
License
Original content